Plasma and Cerebrospinal Fluid Population Pharmacokinetics of Temozolomide in Malignant Glioma Patients

A formula to estimate the approximate surface area if height and weight be known

1916 • 4,502 citations

CLINICAL CALORIMETRY

1916 • 4,077 citations

Response criteria for phase II studies of supratentorial malignant glioma.

1990 • 2,401 citations

World Health Organization classification of tumors

2000 • 1,998 citations

Evaluation of BCNU and/or radiotherapy in the treatment of anaplastic gliomas

1978 • 1,663 citations

Bioanalytical method validation--a revisit with a decade of progress.

2000 • 1,554 citations

Brain Tumors

2001 • 1,527 citations

A phase II study of temozolomide vs. procarbazine in patients with glioblastoma multiforme at first relapse

2000 • 940 citations

Promising Survival for Patients With Newly Diagnosed Glioblastoma Multiforme Treated With Concomitant Radiation Plus Temozolomide Followed by Adjuvant Temozolomide

2002 • 777 citations

Temozolomide: a review of its discovery, chemical properties, pre-clinical development and clinical trials

1997 • 777 citations

Multicenter Phase II Trial of Temozolomide in Patients With Anaplastic Astrocytoma or Anaplastic Oligoastrocytoma at First Relapse

1999 • 762 citations

Phase I trial of temozolomide (CCRG 81045: M&B 39831: NSC 362856)

1992 • 483 citations

The blood-brain and blood-tumor barriers: A review of strategies for increasing drug delivery

2000 • 438 citations

Population pharmacokinetics/pharmacodynamics of docetaxel in phase II studies in patients with cancer.

1998 • 420 citations

Combined modality therapy of operated astrocytomas grade III and IV. Confirmation of the value of postoperative irradiation and lack of potentiation of bleomycin on survival time: A prospective multicenter trial of the scandinavian glioblastoma study group

1981 • 417 citations

Clinical Relevance of MGMT in the Treatment of Cancer

2002 • 415 citations

Antitumor activity and pharmacokinetics in mice of 8-carbamoyl-3-methyl-imidazo[5,1-d]-1,2,3,5-tetrazin-4(3H)-one (CCRG 81045; M & B 39831), a novel drug with potential as an alternative to dacarbazine.

1987 • 386 citations

Multicenter phase II trial of temozolomide in patients with glioblastoma multiforme at first relapse

2001 • 373 citations

Marked inactivation of O6-alkylguanine-DNA alkyltransferase activity with protracted temozolomide schedules

2003 • 365 citations

Irinotecan Therapy in Adults With Recurrent or Progressive Malignant Glioma

1999 • 353 citations

Role of Body Surface Area in Dosing of Investigational Anticancer Agents in Adults, 1991-2001

2002 • 281 citations

Considerations in the Use of Cerebrospinal Fluid Pharmacokinetics to Predict Brain Target Concentrations in the Clinical Setting

2002 • 234 citations

Phase I dose-escalation and pharmacokinetic study of temozolomide (SCH 52365) for refractory or relapsing malignancies

1999 • 205 citations

Effects of adrenal cortical steroids and osmotic blood-brain barrier opening on methotrexate delivery to gliomas in the rodent: the factor of the blood-brain barrier.

1982 • 184 citations

Plasma and cerebrospinal fluid pharmacokinetics of intravenous temozolomide in non-human primates.

2003 • 142 citations

A critique of the role of the blood-brain barrier in the chemotherapy of human brain tumors

1994 • 133 citations

Population pharmacokinetics and concentration–effect relationships of capecitabine metabolites in colorectal cancer patients

2003 • 103 citations

Steroid‐induced CT changes in patients with recurrent malignant glioma

1988 • 100 citations

Plasma and cerebrospinal fluid pharmacokinetic study of topotecan in nonhuman primates.

1993 • 96 citations

Clinical Pharmacokinetics of Irinotecan and Its Metabolites: A Population Analysis

2002 • 94 citations

Chemotherapy for high-grade gliomas

2000 • 79 citations

Role of Population Pharmacokinetics in Drug Development

1997 • 74 citations

Pharmacokinetics of temozolomide in association with fotemustine in malignant melanoma and malignant glioma patients: comparison of oral, intravenous, and hepatic intra-arterial administration

1998 • 71 citations

Population Pharmacokinetic Model for Topotecan Derived From Phase I Clinical Trials

2000 • 68 citations

DNA cross-linking and cytotoxicity in normal and transformed human cells treated in vitro with 8-carbamoyl-3-(2-chloroethyl)imidazo[5,1-d] -1,2,3,5-tetrazin-4(3H)-one.

1984 • 67 citations

Characterisation of urinary metabolites of temozolomide in humans and mice and evaluation of their cytotoxicity

1990 • 65 citations

Plasma and cerebrospinal fluid pharmacokinetics of 9-aminocamptothecin (9-AC), irinotecan (CPT-11), and SN-38 in nonhuman primates

1998 • 61 citations

Population pharmacokinetics of temozolomide in cancer patients.

2000 • 60 citations

Population pharmacokinetics and pharmacodynamics of oral etoposide

2001 • 55 citations

Determination of temozolomide in human plasma and urine by high-performance liquid chromatography after solid-phase extraction

1995 • 55 citations

Improved efficacy of chemotherapy for glioblastoma by radiation-induced opening of blood-brain barrier: clinical results

2001 • 50 citations

Phase I Study of Topotecan Plus Cranial Radiation for Glioblastoma Multiforme: Results of Radiation Therapy Oncology Group Trial 9507

2001 • 48 citations

The blood-brain and blood-tumor barriers: A review of strategies for increasing drug delivery

2000 • 48 citations

Evaluation of the autoinduction of ifosfamide metabolism by a population pharmacokinetic approach using NONMEM

2000 • 47 citations

Radiation-Induced Blood-Brain Barrier Changes: Pathophysiological Mechanisms and Clinical Implications

1998 • 46 citations

Population pharmacokinetics of adjuvant cyclophosphamide, methotrexate and 5-fluorouracil (CMF)

2002 • 44 citations

Pharmacokinetic quantification of the exchange of drugs between blood and cerebrospinal fluid in man

1993 • 42 citations

Therapy of Malignant Brain Tumors

1986 • 42 citations

Population Pharmacokinetics of the Novel Anticancer Agent E7070 During Four Phase I Studies: Model Building and Validation

2002 • 40 citations

Population pharmacokinetics of oxaliplatin

2002 • 38 citations

Radiation-induced blood-brain barrier damage in astrocytoma: relation to elevated gelatinase B and urokinase.

1999 • 29 citations

Population Pharmacokinetics/Toxicodynamics (PK/TD) Relationship of SAM486A in Phase I Studies in Patients with Advanced Cancers

2000 • 28 citations

Principles of Chemotherapy in Brain Neoplasia

1987 • 17 citations

A Pharmaceutical Industry Perspective

2004 • 14 citations